Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimo Stine

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Medical and Pediatric Oncology|February 12, 2002
Comparison of manual and automated leukocyte counts for determination of the absolute neutrophil count: application to a pediatric oncology clinicDavid M Parham, Ruth Ready, Kimo Stine, et al.
Cardiovascular Toxicology|January 12, 2026
Correction: Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot StudyTaewon Lee, David Douglass, Kimo Stine, et al.
Cardiovascular Toxicology|October 17, 2025
Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot StudyTaewon Lee, David Douglass, Kimo Stine, et al.
Pediatric Blood & Cancer|October 28, 2014
Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)James B Bussel, Loan Hsieh, George R Buchanan, et al.
Journal of Applied Toxicology : JAT|February 24, 2022
MicroRNA-34a-5p as a promising early circulating preclinical biomarker of doxorubicin-induced chronic cardiotoxicityVarsha G Desai, Vikrant Vijay, Taewon Lee, et al.
Pediatric Blood & Cancer|May 3, 2016
Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 StudyCindy Neunert, Jenny Despotovic, Kristina Haley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemiaSima Jeha, Bassem Razzouk, Michael Rytting, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology GroupMark L Bernstein, Meenakshi Devidas, Dominique Lafreniere, et al.
Pediatric Blood & Cancer|June 16, 2011
Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopeniaRachael F Grace, Carolyn M Bennett, A Kim Ritchey, et al.
Human Molecular Genetics|February 2, 2013
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia AJérôme Lane, Paul J McLaren, Lucy Dorrell, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Medical and Pediatric Oncology|February 12, 2002
Comparison of manual and automated leukocyte counts for determination of the absolute neutrophil count: application to a pediatric oncology clinicDavid M Parham, Ruth Ready, Kimo Stine, et al.
Cardiovascular Toxicology|January 12, 2026
Correction: Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot StudyTaewon Lee, David Douglass, Kimo Stine, et al.
Cardiovascular Toxicology|October 17, 2025
Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot StudyTaewon Lee, David Douglass, Kimo Stine, et al.
Pediatric Blood & Cancer|October 28, 2014
Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)James B Bussel, Loan Hsieh, George R Buchanan, et al.
Journal of Applied Toxicology : JAT|February 24, 2022
MicroRNA-34a-5p as a promising early circulating preclinical biomarker of doxorubicin-induced chronic cardiotoxicityVarsha G Desai, Vikrant Vijay, Taewon Lee, et al.
Pediatric Blood & Cancer|May 3, 2016
Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 StudyCindy Neunert, Jenny Despotovic, Kristina Haley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemiaSima Jeha, Bassem Razzouk, Michael Rytting, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology GroupMark L Bernstein, Meenakshi Devidas, Dominique Lafreniere, et al.
Pediatric Blood & Cancer|June 16, 2011
Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopeniaRachael F Grace, Carolyn M Bennett, A Kim Ritchey, et al.
Human Molecular Genetics|February 2, 2013
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia AJérôme Lane, Paul J McLaren, Lucy Dorrell, et al.
Pageof 1